Inoue M, Sekiguchi T, Harasawa S, Miwa T, Miyoshi A
Dept. of General Medicine, Hiroshima University, Japan.
Scand J Gastroenterol Suppl. 1993;195:36-8; discussion 38-9. doi: 10.3109/00365529309098326.
In 240 patients with symptoms of dyspepsia, recruited consecutively and investigated in 12 hospitals in Japan, 24.2% were diagnosed having organic dyspepsia; 75.8% had functional dyspepsia, of whom 63.2% were diagnosed by the investigator having dysmotility-like, 13.7% ulcer-like, 11.5% reflux-like, and 11.5% non-specific dyspepsia. There was, however, considerable overlap of symptom profiles. Cisapride therapy initiated in functional dyspeptic patients resulted in moderate or marked improvement in 79.1% of the patients with the highest response rates for dysmotility-like (85.2%), reflux-like (81.0%), and non-specific dyspepsia (76.1%) (versus 52.0% for ulcer-like dyspepsia).
在日本12家医院连续招募并接受调查的240例有消化不良症状的患者中,24.2%被诊断为器质性消化不良;75.8%为功能性消化不良,其中63.2%被研究者诊断为动力障碍样型,13.7%为溃疡样型,11.5%为反流样型,11.5%为非特异性消化不良。然而,症状特征存在相当大的重叠。对功能性消化不良患者开始使用西沙必利治疗后,79.1%的患者有中度或明显改善,其中动力障碍样型(85.2%)、反流样型(81.0%)和非特异性消化不良(76.1%)的缓解率最高(相比之下,溃疡样消化不良为52.0%)。